(Q45356467)

English

Induction of a protective immune response to rabies virus in sheep after oral immunization with transgenic maize, expressing the rabies virus glycoprotein

scientific article published on 27 June 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 December 2017

Induction of a protective immune response to rabies virus in sheep after oral immunization with transgenic maize, expressing the rabies virus glycoprotein (English)

1 reference

Europe PubMed Central

13 December 2017

0 references

0 references

object named as

rabies virus

1 reference

based on heuristic

inferred from title

author name string

Elizabeth Loza-Rubio

1

1 reference

Europe PubMed Central

13 December 2017

Edith Rojas-Anaya

2

1 reference

Europe PubMed Central

13 December 2017

Juan López

3

1 reference

Europe PubMed Central

13 December 2017

María Teresa Olivera-Flores

4

1 reference

Europe PubMed Central

13 December 2017

Miguel Gómez-Lim

5

1 reference

Europe PubMed Central

13 December 2017

Graciela Tapia-Pérez

6

1 reference

Europe PubMed Central

13 December 2017

language of work or name

0 references

publication date

27 June 2012

1 reference

Europe PubMed Central

13 December 2017

1 reference

Europe PubMed Central

13 December 2017

30

1 reference

Europe PubMed Central

13 December 2017

37

1 reference

Europe PubMed Central

13 December 2017

5551-5556

1 reference

Europe PubMed Central

13 December 2017

Detection of multiple strains of rabies virus RNA using primers designed to target Mexican vampire bat variants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Observations of sylvatic rabies in Northern Argentina during outbreaks of paralytic cattle rabies transmitted by vampire bats (Desmodus rotundus).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Landscape risk factors for attacks of vampire bats on cattle in Sao Paulo, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Haematophagous bats in Brazil, their role in rabies transmission, impact on public health, livestock industry and alternatives to an indiscriminate reduction of bat population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Rabies transmitted by vampire bats to humans: an emerging zoonotic disease in Latin America?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Rapid clearance of SAG-2 rabies virus from dogs after oral vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Era vaccine-derived cases of rabies in wildlife and domestic animals in Ontario, Canada, 1989-2004.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

The immune response to rabies virus infection and vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Expression of rabies virus glycoprotein from a recombinant vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Immunisation with canarypox virus expressing rabies glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Studies on the structures and antigenic properties of rabies virus glycoprotein analogues produced in yeast cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Recombinant rabies virus glycoprotein synthesis in bioreactor by transfected Drosophila melanogaster S2 cells carrying a constitutive or an inducible promoter

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Rabies ribonucleocapsid as an oral immunogen and immunological enhancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Oral rabies vaccination in north america: opportunities, complexities, and challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Oral vaccination against raccoon rabies: landscape heterogeneity and timing of distribution influence wildlife contact rates with the ONRAB vaccine bait

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Vaccinia virus as a vaccine delivery system for marsupial wildlife

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Plants as bioreactors for the production of vaccine antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Transgenic rice expressing amyloid β-peptide for oral immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Expression of the rabies virus glycoprotein in transgenic tomatoes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Immunization against rabies with plant-derived antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Expression of rabies virus G protein in carrots (Daucus carota).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Immune responses to hemagglutinin-neuraminidase protein of peste des petits ruminants virus expressed in transgenic peanut plants in sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Expression of the Newcastle disease virus fusion protein in transgenic maize and immunological studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Production and localization of recombinant pharmaceuticals in transgenic seeds

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Statistical issues in longitudinal data analysis for treatment efficacy studies in the biomedical sciences

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

High level expression of surface glycoprotein of rabies virus in tobacco leaves and its immunoprotective activity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

A corn-based delivery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Vaccine production in plant systems--an aid to the control of viral diseases in domestic animals: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Plant-produced vaccines: promise and reality

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Immunogenicity of a plant-derived edible rotavirus subunit vaccine transformed over fifty generations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Analytical strategies to investigate plant N-glycan profiles in the context of plant-made pharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Corn as a production system for human and animal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Degradation of Cry1Ab protein from genetically modified maize (MON810) in relation to total dietary feed proteins in dairy cow digestion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Oral tolerance in humans: failure to suppress an existing immune response by oral antigen administration.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Low-dose exposure and immunogenicity of transgenic maize expressing the Escherichia coli heat-labile toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

The mucosal immune response to plant-derived vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.039

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.06.039

1 reference

Europe PubMed Central

13 December 2017

1 reference

Europe PubMed Central

13 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45356467&oldid=2075579842"